1. Home
  2. Research
  3. Research Groups
  4. Surgical research in urology and renal trasplantation

Surgical research in urology and renal trasplantation

Search for publications

Only original articles, editorials, guidelines.

  • Artiles Medina A, Aumatell J, González-Padilla DA, Pichler R, Scilipoti P, Contieri R, Subiela JD.

    The updated 2021 EAU risk groups for non-muscle-invasive bladder cancer: what have we learned four years after implementation?

    Minerva Urology and Nephrology . : .

    [doi:10.23736/S2724-6051.26.06915-6]

  • Albers Acosta E, Subiela JD, Pelari-Mici L, Saavedra Centeno M, López-Fando Lavalle L, Toquero Diez P, Romero-Laorden N, Pichler R, Scilipoti P, San-José Manso L.

    Perioperative Management of Upper Tract Urothelial Carcinoma: Current Evidence and Future Directions.

    UROLOGIA INTERNATIONALIS . : 1-15.

    [doi:10.1159/000551611]

  • Caño-Velasco J, Luis-Cardo A, Moreno-Cortés JC, Carrasco-Loras L, Astudillo-Campoverde J, Subiela JD, Lozano-Palacio F, Campistol-Torres M, Pichler R, Partl A, Lackner F, Giudice FD, Carino D, García-Martín LA, Salamanca-Blanco P, Bielsa-Carrillo A, Pastor-Cordero AM, Bataller-Monfort V, Tello-Delsors A, Polanco-Pujol L, Lafuente-Puentedura A, Aragón-Chamizo J, Herranz-Amo F, Barbas-Bernardos G, González-Padilla DA, Villacampa-Aubá F, Sánchez-Zalabardo D, Robles-García JE, Miñana-López B, Moschini M, Soria F, D'Andrea D, Mertens LS, Teoh JYC, Albisinni S, Pradere B, Hernández-Fernández C.

    Impact of intravesical BCG Therapy on quality of life in non-muscle-invasive bladder cancer: a prospective evaluation using the FACT-Bl questionnaire.

    Actas Urologicas Espanolas . : 501937-501937.

    [doi:10.1016/j.acuroe.2026.501937]

  • Willisch P, Vázquez-Barreiro B, Plata A, Belmonte IC, Guardia G, Del Castillo-Acuña R, Francolini G, Franzese C, Henríquez JDS, Couñago F, López-Campos F.

    Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications.

    Clinical & Translational Oncology . : .

    [doi:10.1007/s12094-026-04350-4]

  • Molina-Cerrillo J, Alonso-Gordoa T.

    Re: Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer.

    EUROPEAN UROLOGY . : .

    [doi:10.1016/j.eururo.2026.04.007]

  • Falcón A, Cote GM, Molina-Cerrillo J, Le Cesne A, Rocha P, Bockorny B, Paez D, Martin-Broto J, Chawla SP, Martinez S, Kahatt C, Alfaro V, Siguero M, Jimenez J, Custodio A, Alonso-Orduña V, López C, Kollár A, Soto-Castillo JJ, Paz-Ares L.

    Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumors.

    INVESTIGATIONAL NEW DRUGS . : .

    [doi:10.1007/s10637-026-01616-0]

  • Fernández-Conejo G, González Álvarez C, Del Olmo Durán P, Tagalos Muñoz A, Sanz Mayayo E, Diez Nicolás V, García Barreras S, Subiela Henríquez JD, Rodríguez-Patrón R, Pérez-Fernández E, Gómez Dos Santos V, Burgos Revilla FJ.

    Learning curve of Versius-assisted radical prostatectomy: role of prior experience and proctoring.

    BJU INTERNATIONAL . : .

    [doi:10.1111/bju.70405]

  • Chernysheva D, Gómez Gómez E, Burgos Revilla J, Fernández Conejo G, García Barreras S, Linares Espinós E, Gómez Villanueva A, Domínguez Esteban M, Mera Errasti A, Breda A, Fanti S, Bjartell A, Padhani AR, Sanguedolce F.

    Imaging modalities in advanced prostate cancer: Interim analysis of the Spanish cohort of the RING registry.

    Actas Urologicas Espanolas . : 502057-502057.

    [doi:10.1016/j.acuroe.2026.502057]

  • Herrera-Martínez Y, Gómez-Bermejo MÁ, Araujo-Castro M, Minguez-Ojeda C, Galvez-Moreno MA, Molina Puerta MJ, Herrera-Martínez AD.

    Differences in Body Composition in Patients with Pheochromocytomas and Age- and Sex-Matched Non-Functioning Adrenal Tumors: A Matched Cohort Study.

    Endocrine Practice . : .

    [doi:10.1016/j.eprac.2026.08.007]

  • Rescigno P, Taha T, Fita MJ, Matthews D, Fujita K, Lolli C, DI Costanzo F, Juárez A, Ürün Y, Yazgan SC, Li H, Facchini G, Quiroga MN, Sammarco E, Bögemann M, Santini D, Baranseh J, Roviello G, Kopp RM, Fiala O, Büttner T, Carrozza F, Ansari J, Tural D, Conteduca V, Molina-Cerrillo J, Alonso-Gordoa T, Bourlon MT, Palacios GA, Paolieri F, Zgura A, DI Rocco R, Lacerenza LG, Matrana MR, Martignetti A, Massari F, Soares A, Monteiro FS, Bastos DA, Gaughan L, Wenzel M, Mandel P, Banna GL, Santoni M.

    Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study.

    Minerva Urology and Nephrology . : .

    [doi:10.23736/S2724-6051.26.06453-0]

  • Rizzo M, Buti S, Fiala O, Incorvaia L, Molina-Cerrillo J, Bourlon MT, Fukuokaya W, Urabe F, Park SH, Mayrhofer K, Pichler R, Niedersuess-Beke D, Taha T, Büttner T, Bamias A, Seront E, Santini D, Stumbo L, Rodriguez-Vida A, Massari F, Monteiro FSM, Soares A, Grande E, Santoni M.

    Baseline Disease Characteristics and Platinum Sensitivity as Predictors of Outcomes in Sequential Therapy with Platinum-Based Chemotherapy, Avelumab Maintenance, and Enfortumab Vedotin in Advanced Urothelial Carcinoma (ARON-2EV Study).

    Targeted Oncology . : .

    [doi:10.1007/s11523-026-01238-9]

  • Maiorano BA, Maruzzo M, Slusarczyk A, Subiela JD, Soria F, Albisinni S, Mari A, Claps F, Contieri R, Gallioli A, Caño-Velasco J, D'Andrea D, Laukhtina E, Marcq G, Krajewski W, Grobet-Jeandin E, Afferi L, Del Giudice F, Rizzo A, Moschini M, Mertens LS, Cigliola A, Mercinelli C, Piacentini M, Santoni M, Pradère B, Necchi A.

    Comparative efficacy of perioperative systemic therapies for muscle-invasive bladder cancer: a network meta-analysis of randomized trials.

    ESMO Open . 11(8): 108329-108329.

    [doi:10.1016/j.esmoop.2026.108329]

  • Slusarczyk A, Moschini M, Krajewski W, Scilipoti P, Contieri R, Claps F, Subiela JD, Mertens LS, Mori K, Velasco JC, Soria F, Grobet-Jeandin E, Tully K, Garbas K, Del Olmo Durán P, Lijnen RAG, Fertitta G, Reynard M, Katzendorn O, Puentedura AL, Longoni M, D'Andrea D, Del Giudice F, Gallioli A, Laukhtina E, Marcq G, Mari A, Afferi L, Albisinni S, Amodeo A, Boorjian SA, Briganti A, Montorsi F, Shariat SF, Gontero P, Radziszewski P, Pradere B.

    Predicting the Development of BCG-unresponsive Disease Among Patients with High-grade Non-muscle-invasive Bladder Cancer: An International Multicenter Analysis.

    European Urology Oncology . : .

    [doi:10.1016/j.euo.2026.06.005]

  • Subiela JD, Gomis Sellés E, López Campos F, Aumatell J, González-Padilla DA, Balbás ÁG, López-Curtis D, Vera Barragán V, Caño-Velasco J, Picola Brau N, de Pablos-Rodríguez P, Gómez Rivas J, San-José Manso L, Burgos Revilla FJ, Barletta F, Alongi F, Zamboglou C, Nicosia L, Shelan M, Conde-Moreno AJ, Gajate P, Guerrero P, Buisan Ò, Couñago F.

    Whole-pelvic Versus Prostate-only Radiotherapy in Clinically Node-negative High-Risk Localised Prostate Cancer: A Systematic Review and Meta-analysis with Reconstructed Individual-patient Data.

    CLINICAL ONCOLOGY . 59: 104329-104329.

    [doi:10.1016/j.clon.2026.104329]

  • Garcia-Carbonero R, Cote GM, Le Cesne A, Antón-Pascual B, Alonso-Gordoa T, Falcon A, Gil-Torralvo A, Martínez S, Kahatt C, Alfaro V, Zubiaur P, Jimenez J, Siguero M, Molina-Cerrillo J.

    Lurbinectedin plus irinotecan in pretreated gastroenteropancreatic neuroendocrine neoplasms: results of a phase II expansion cohort.

    ESMO Open . 11(10): 108534-108534.

    [doi:10.1016/j.esmoop.2026.108534]

  • Corvino R, Basile G, Santarelli V, Asero V, De Berardinis E, Sciarra A, Vittori L, Abu-Ghanem Y, Nair R, Khan MS, Thurairaja R, Barod R, Krajewski W, Laszkiewicz J, Albisinni S, Mori K, Guerrero-Ramos F, D'Andrea D, Gallioli A, Laukhtina E, Suleja A, Grobet-Jeandin E, Mari A, Mertens LS, Moschini M, De Angelis M, Scillipoti P, Soria F, Bosio A, Teoh J, Claps F, Amodeo A, Slusarczyk A, Contieri R, Subiela D, Tagalos A, Tully KH, Pichler R, Antonelli A, Bertolo R, Veccia A, Malandra S, Hurle R, Sormani F, Crocetto F, Mayr R, Porreca A, Simone G, Tuderti G, Rocco B, Simonato A, Simonato FA, Marcq G, Gontero P, Tian Z, Karakiewicz P, Chung BI, Pradere B, Del Giudice F.

    Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group.

    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS . : .

    [doi:10.1016/j.urolonc.2026.08.007]

  • Sridharan K, Fiala O, Sivaramakrishnan G, Matrana MR, Büttner T, Kucharz J, Molina Cerrillo J, Giannatempo P, Myint ZW, Gómez de Liaño A, Pirshtuk A, Mota A, Kanesvaran R, Ürün Y, Angel M, Soule T, Massari F, Bellmunt J, Gupta S, Santoni M.

    Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis.

    EXPERT OPINION ON BIOLOGICAL THERAPY . : 1-11.

    [doi:10.1080/14712598.2026.2727098]